marcus evans north america conferences

10th Product Selection & Pipeline Optimization for Generics

Implementing Actionable Strategies to Drive Portfolio Diversification

12-13 Sep 2017
Philadelphia, PA, United States of America


Why You Should Attend

10th Product Selection & Pipeline Optimization for Generics

This 10th installment of the marcus evans Product Selection & Portfolio Optimization for Generics event will bring together key players in the Generics industry from a variety of facets including: business development, corporate strategy, portfolio management and project management.  Delegates will discuss actionable strategies and best practices in forging new business opportunities, selecting the right products that will fill in portfolio gaps, and conducting risk assessments frequently to ensure in a high quality and robust portfolio.

This conference will feature a variety of content rich presentations on portfolio optimization, product selection and rationalization, partnerships, alliance management, budgeting and forecasting for future projects, and capitalizing on new opportunities to drive business growth.

Key Topics

  • Conduct a portfolio analysis to determine which products will optimize the portfolio
  • Identify key attributes and best methods to successfully maintain a portfolio
  • Assess product viability through product rationalization to achieve maximum ROI
  • Develop partnerships through consolidations or strategic alliances to ensure in successful generic drug development
  • Budget & Forecast for projects strategically to ensure corporate goals are being achieved
  • Previous Attendees Include

    Aiping Pharmaceuticals, Albemarle Corp, Alcami Corporation, Amneal Pharmaceuticals, Apotex Inc., Arent Fox LLP, Bachem Americas, Breckenridge Pharma, Camargo Pharmaceutical, Canda Pharmaceuticals, CIPLA, Coldstream Labs, CPL, EZRA Ventures LLC, Federal Trade Commission Health Care Division, Fresenius Kabi USA LLC, G&W Laboratories, Goodwin Procter, Greenstone LLC, Handa Pharmaceuticals LLC, Impax Laboratories, Johnson Matthey Inc, Klus Pharma Inc, Lehigh Valley Technologies, Lupin Pharmaceuticals Inc, Lupin Somerset, Mallinckrodt Pharmaceuticals, Mayne Pharma, MSN Pharma, Noramco Inc, Office of Generic Drugs CDER FDA, PAR Pharmaceuticals, Pharmascience Inc. ,Pharmathen UK ,Procos S.p.A (CBC Group), PuraCap Pharmaceutical, Renaissance Pharma, Sandoz Inc., Saptalis Pharmaceuticals LLC, Sigmapharm Laboratories, Stason Pharmaceuticals, Sun Pharmaceuticals, Teva API Inc, Torrent Pharma, United States Pharmacopeia, Upsher-Smith Laboratories Inc., Wockhardt USA LLC


    Why Choose marcus evans?

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.






    Practical Insights From

    Kaushik Lakkaraju
    Director, Business Development, Portfolio & Strategic Marketing, Region North America
    Fresenius Kabi USA

    Sami Yusuf, Pharm. D., M.S., MBA
    Senior Director, Corporate Development, Head of Generic Pipeline
    Upsher-Smith Laboratories, Inc.

    Richard A. Hoyt
    Vice President, Business Development and Licensing
    Mallinckrodt Pharmaceuticals

    Erika Geimonen, Ph.D.
    Vice President of Business Development
    Amring Pharmaceuticals

    Gopal Venkatesan
    Vice President, Business Development
    Wockhardt USA LLC

    Mahen Gundecha
    Head of Alliance Management
    Sandoz Inc.

    Funso Olufade
    Director, Strategic Defense
    Daiichi Sankyo Europe GmbH

    Click Here For Full Agenda

    Voice of Our Customers
    • “The content of the event was very up to date and well explained. Q + A very interactive.” -Teva Pharmaceuticals
    • “Relevant and useful topics from industry perspective.” -Abbott
    • “Terrific chance to connect with other industry traders to exchange ideas and explore solutions to the challenges we all face.” -OrchidPharma
    Join the Discussion

    Follow on LinkedIn





    Event Contact

    For all enquiries regarding speaking, sponsoring and attending this conference contact:

    John Hummel


    NBC Tower, 9th Floor
    455 North Cityfront Plaza Drive
    Chicago, IL 60611

    Telephone:
    312-540-3000 Ext: 6327
    Fax: 312.894.6304
    Email: johnh@marcusevansch.com